India Leads Global Health Dialogue at Drug Regulatory Conference

Union Health Minister J P Nadda highlighted India's commitment to global health advancement during the 19th International Conference of Drug Regulatory Authorities. Emphasizing international collaboration, he discussed India's role as a pharmaceutical leader, focusing on affordable access to medicines and strong regulatory frameworks, reflecting the country's dedication to global healthcare standards.

Union Health Minister J P Nadda emphasized the importance of international collaboration in advancing global health solutions during the 19th International Conference of Drug Regulatory Authorities in India.

Highlighting India's role as a pharmaceutical leader, Nadda discussed how the country rapidly expanded its healthcare infrastructure and ensured affordable access to essential medicines worldwide. The nation's robust response to the COVID-19 pandemic underscored its commitment to global health security.

The conference, attended by representatives from over 120 countries, aims to enhance regulatory cooperation to address global health challenges such as antimicrobial resistance and equitable healthcare access. The event underscores India's dedication to adhering to global quality standards while promoting regulatory transparency and efficiency.

(With inputs from agencies.)